Drug Toxicity

In this video, J. Nicholas Bodor, MD, PhD, MPH, assistant professor in the department of hematology/oncology at Fox Chase Cancer, offers advice to new residents seeing patients with EGFR-mutated lung cancer.

In this video, J. Nicholas Bodor, MD, PhD, MPH, assistant professor in the department of hematology/oncology at Fox Chase Cancer, discusses the changing treatment landscape in EGFR-mutated lung cancer.

Paolo Tarantino, MD, discusses the role of collaborative management of patients with metastatic breast cancer.

  Healio spoke to Emma Rossi, MD, gynecological oncologist at Duke Cancer Center, about combining different therapeutic modalities for advanced endometrial cancer.

Women of childbearing age with hidradenitis suppurativa are often prescribed teratogenic medications, and the majority do not receive physician-led counsel on how these medications could impact childbearing, according to published data.

In this video, Thomas Waddington, MD, assistant clinical professor in the department of medicine, division of pulmonary and critical care medicine at City of Hope National Medical Center, discusses what pulmonologists should be staying up to date on in terms of lung cancer treatments.

In this video, Eugene Shenderov, MD, PhD, assistant professor of oncology at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore, MD, discusses a phase I/II multicenter first-in-human trial of DS-7300, an anti-B7-H3, which was studied in patients with advanced solid tumors.

Some newly approved as well as several long-term use medications have been recently associated with acute retinal toxicity, according to a poster presentation at the Women in Ophthalmology Summer Symposium.

Canagliflozin, an SGLT2 inhibitor, may lead to rosuvastatin toxicity when they are prescribed together, according to a case report published in the Annals of Internal Medicine.